ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $895,436 | -14.3% | 52,273 | -2.1% | 0.01% | -11.1% |
| Q4 2022 | $1,044,431 | +81.6% | 53,369 | +48.1% | 0.01% | +80.0% |
| Q3 2022 | $575,000 | +7.1% | 36,030 | -7.7% | 0.01% | 0.0% |
| Q2 2022 | $537,000 | -48.9% | 39,054 | -41.1% | 0.01% | -54.5% |
| Q1 2022 | $1,051,000 | -35.4% | 66,294 | -11.1% | 0.01% | -38.9% |
| Q4 2021 | $1,628,000 | -30.2% | 74,577 | -4.4% | 0.02% | -18.2% |
| Q3 2021 | $2,331,000 | -36.7% | 77,970 | -6.2% | 0.02% | -33.3% |
| Q2 2021 | $3,681,000 | -25.8% | 83,103 | -25.6% | 0.03% | -31.2% |
| Q1 2021 | $4,959,000 | -9.3% | 111,772 | +12.0% | 0.05% | -22.6% |
| Q4 2020 | $5,470,000 | +240.0% | 99,753 | +41.7% | 0.06% | +158.3% |
| Q3 2020 | $1,609,000 | +2.2% | 70,381 | -6.5% | 0.02% | +14.3% |
| Q2 2020 | $1,575,000 | +14.6% | 75,246 | -23.6% | 0.02% | 0.0% |
| Q1 2020 | $1,374,000 | -40.5% | 98,491 | -2.9% | 0.02% | +16.7% |
| Q4 2019 | $2,309,000 | +33.6% | 101,466 | +44.6% | 0.02% | +63.6% |
| Q3 2018 | $1,728,000 | +54.0% | 70,185 | +22.8% | 0.01% | +57.1% |
| Q2 2018 | $1,122,000 | – | 57,177 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
| RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
| Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
| Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
| TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
| Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
| COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
| Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
| Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
| MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |